FORMULATION, STABILITY, PHARMACOKINETIC, AND MODELING STUDIES FOR TESTS OF SYNERGISTIC COMBINATIONS OF ORALLY AVAILABLE APPROVED DRUGS AGAINST EBOLA VIRUS IN VIVO
Technology
E-191-2023
Patent ID
E-191-2023-0-US-01
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/147,587
IC
NIAID
Date Filed
Date Issued
Patent PDF